| 摘要 |
<p>Novel multi-component conjugates are provided having at least two components which are superoxide dismutase and catalase. Novel therapeutic agents utilising these conjugates are provided which are effective to reduce harmful levels of superoxide and hydroxyl free radicals in body tissues.</p> |
